CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

ONCOLOGY. Vol. 20 No. 14
Pages: 1  2  
Next
Report From ASCO 

Study of the Oncology Workforce Seeks to Determine US Cancer Care Needs for the Future

December 1, 2006

Will there be a shortage of oncologists in 2015? This is a question that needs to be answered now in order to design and promote programs and policies that can help assure that Americans have access to high-quality cancer care in the future. All signs point to a significant increase in cancer rates as the baby boomers reach 65 years of age and older.[1] Additionally, the 5-year survival rate has risen to 79% for children and 64% for adults[2] and will likely lead to a significant rise in individuals with a need for continuing care and observation.

Comprehensive Assessment

Yet the production of new clinical oncologists has remained fairly constant (400 to 500 per year[3]) over the past decade, and we do not know how many of today's practicing oncologists will still be seeing patients in 2015. While there seems to be growing interest in clinical oncology fellowships among medical students and residents,[4] we do not know whether the numbers of training/fellowship positions will produce enough clinical oncologists to meet future needs.

In order to conduct a comprehensive assessment of the current and likely future supply and demand for practicing oncologists, the American Society for Clinical Oncology (ASCO) has contracted with the Association of American Medical Colleges' (AAMC) Center for Workforce Studies. The Center is conducting the study in cooperation with the ASCO Workforce in Oncology Task Force, chaired by Michael Goldstein, MD, a medical oncologist at Beth Israel Deaconess Medical Center, Boston. The Task Force includes leaders representing a number of areas: program directors, oncology fellows, health services researchers, community oncologists, academic oncologists, and workforce specialists.

Main Areas of Focus

The 18-month study focuses on medical oncologists, hematologists/oncologists, gynecologic oncologists, and pediatric hematologists/oncologists. The study includes a detailed analysis of existing data on the incidence of cancer and current utilization patterns and incorporates new knowledge on practice patterns and career expectations gathered from surveys of practicing clinical oncologists, program directors, fellows completing training, and new entrants in fellowship programs. Information gathered from the study will be used to model future supply and demand. The study contains four main areas of focus:

(1) Assessment of the supply and distribution of the oncologist workforce, including geographic and demographic data on oncologists currently in practice and a survey of attitudes of practicing oncologists regarding factors influencing physician supply and productivity;

(2) Assessment of oncologists in training, including demographic data for applicants to fellowship programs and surveys of fellows entering and graduating from fellowship programs and program directors to determine initial career choices and expectations;

(3) Analysis of existing oncology data, including age-specific cancer incidence rates, population projections and Medicare claims data; and

Pages: 1  2  
Next
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
IMAGE IQ

A 48-Year-Old Woman With Irregular Vaginal Bleeding
Brian Morse, MD1 , June 10, 2013

A 48-year-old female presents with complaints of irregular vaginal bleeding and postcoital bleeding. Images from a PET/CT and pelvis MRI reveal characteristic findings. What is your diagnosis?

More Image IQs 

 
FROM PHYSICIANS PRACTICE
Key Differences between FQHCs and RHCs
Chastity Werner, RHIT, June 13, 2013
FQHCs and RHCs take up a unique niche among physician practices. And that affects compensation and billing.
Improving Care Coordination in Your Practice
Susanne Madden,  June 12, 2013
Practices are feverishly working to control the rising costs of healthcare - effective care coordination can help.
Refunding Overpayments: Two Options for Medical Practices
Ericka L. Adler,  June 12, 2013
Medicare and Medicaid providers must return overpayments once identified. Here are two different refund approaches for practices to consider when necessary.
Four Easy Ways to Boost Patient Time of Service Collections
Aubrey Westgate,  June 12, 2013
Simple ways your medical practice staff can increase the likelihood patients will pay when presenting for appointments.
iPad Alternatives for Mobile Physicians
Marisa Torrieri, June 11, 2013
As more physicians are seeing the merits of media tablets, the market is expanding, too.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Papillary Thyroid Carcinoma
  • Robotic-Assisted Radical Prostatectomy: Who Is Benefiting?
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • A 48-Year-Old Woman With Irregular Vaginal Bleeding
  • Cannabis Linked to Decreased Bladder Cancer Risk
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Rising PSA Level in a 46-Year-Old Man
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • ASCO: Dabrafenib Shows Activity in BRAF-Mutated NSCLC Patients
  • Preventing Burnout in Oncology
  • ASCO: Yoga Reduces Insomnia in Breast Cancer Patients Treated With Hormone Therapy
  • Physical Activity Across the Cancer Continuum
  • Exercise After Cancer Diagnosis: Time to Get Moving
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Preventing Exposure to Hazardous Drugs
  • ASCO: Vinegar Screening Significantly Reduces Cervical Cancer Mortality
  • ASCO: Sulforaphane in Prostate Cancer Found Worthy of Further Investigation
  • Study: Recurrent Heartburn Ups Risk for Throat Cancer
  • HER2-Directed Therapy for Metastatic Breast Cancer
  • Accelerated Partial-Breast Irradiation: The Current State of Our Knowledge
  • It’s Time for Clinicians to Reconsider Their Proscription Against the Use of Soyfoods by Breast Cancer Patients
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • ASCO: No Benefit From Avastin in Newly Diagnosed Glioblastoma
Click here to subscribe to our newsletter



CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy